Dezinamide
Based on 1 Customer Validation
Dezinamide (ADD94057) is an antiepileptic agent. Dezinamide binds to the voltage-sensitive sodium channel.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 99.47%
- CAS No.: 91077-32-6
- Formule: C11H11F3N2O2
- Masse moléculaire:260.21
-
Stockage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
-
Solvant et solubilité
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
Description
Chemical Information
-
CAS No. 91077-32-6
-
Appearance Solid
-
Masse moléculaire 260.21
-
Formule C11H11F3N2O2
-
Color White to off-white
-
SMILES
O=C(N1CC(C1)OC2=CC=CC(C(F)(F)F)=C2)N
-
Synonyms
AHR11748; AN051; ADD94057
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Solvant et solubilité
In Vitro:
DMSO : 100 mg/mL (384.30 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Pureté et documentation
-
Fiche technique (266 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Fisher R, et al. Clobazam, oxcarbazepine, tiagabine, topiramate, and other new antiepileptic drugs. Epilepsia. 1995;36 Suppl 2:S105-14. [Content Brief]
[2]. Privitera MD, et al. Dezinamide for partial seizures: results of an n-of-1 design trial. Neurology. 1994 Aug;44(8):1453-8. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.8430 mL | 19.2152 mL | 38.4305 mL | 96.0762 mL |
| 5 mM | 0.7686 mL | 3.8430 mL | 7.6861 mL | 19.2152 mL | |
| 10 mM | 0.3843 mL | 1.9215 mL | 3.8430 mL | 9.6076 mL | |
| 15 mM | 0.2562 mL | 1.2810 mL | 2.5620 mL | 6.4051 mL | |
| 20 mM | 0.1922 mL | 0.9608 mL | 1.9215 mL | 4.8038 mL | |
| 25 mM | 0.1537 mL | 0.7686 mL | 1.5372 mL | 3.8430 mL | |
| 30 mM | 0.1281 mL | 0.6405 mL | 1.2810 mL | 3.2025 mL | |
| 40 mM | 0.0961 mL | 0.4804 mL | 0.9608 mL | 2.4019 mL | |
| 50 mM | 0.0769 mL | 0.3843 mL | 0.7686 mL | 1.9215 mL | |
| 60 mM | 0.0641 mL | 0.3203 mL | 0.6405 mL | 1.6013 mL | |
| 80 mM | 0.0480 mL | 0.2402 mL | 0.4804 mL | 1.2010 mL | |
| 100 mM | 0.0384 mL | 0.1922 mL | 0.3843 mL | 0.9608 mL |
Dezinamide Related Classifications
HY-111157 Related Classifications
Powered by Bioz